Zealand Pharma has acquired 1 company, including 1 in the last 5 years.
Zealand Pharma’s largest acquisition to date was in 2020, when it acquired Valeritas for $23M. Zealand Pharma has acquired in 1 US state. The Company’s most targeted sectors include medical products (100%).
Sydmarken 11,
Soborg,
2860
Denmark,
+45 88 77 36 00
www.zealandpharma.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
||
|---|---|---|---|---|---|---|---|---|
| 2020-02-10 |
Valeritas, Inc. · Medical Products
Bridgewater, New Jersey · www.valeritas.com Valeritas, Inc. is a commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies. Valeritas, Inc. designed the first commercialized product, the V-Go Wearable Insulin Delivery Device, or V-Go, to help patients with Type 2 diabetes who require insulin to achieve and maintain their target blood glucose goals.
|
23
1.0x REVENUE |
Special Situations/Distressed |
Zealand Pharma
|
- |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
